Rene Russo - 01 Jan 2025 Form 4/A - Amendment Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Kevin Brennan, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
01 Jan 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Jun 2025, 16:55:49 UTC
Date Of Original Report
03 Jan 2025
Previous filing
03 May 2024
Next filing
16 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Russo Rene PRESIDENT AND CEO, Director 828 WINTER STREET, SUITE 300, WALTHAM /s/ Kevin Brennan, Attorney-in-Fact 18 Jun 2025 0001722066

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XLO Common Stock 244,883 01 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 3, 2025, the Reporting Person filed a Form 4 that inadvertently omitted a power of attorney. This amendment is being filed solely to add the power of attorney attached hereto as Exhibit 24.1.